Navigation Links
RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development
Date:9/8/2019

RoosterBio, Inc, a biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of the Regenerative Medicine industry’s first human umbilical cord (hUC) MSC paired cell and media system designed for product development. RoosterBio continues to simplify MSC production by introducing an unprecedented step-change in quantifiable productivity metrics. RoosterVial™-hUC-MSC-XF, allows scientists to generate billions of perinatal cells in a fraction of the time when paired with RoosterBio’s existing xeno-free hMSC plug and play systems. This product line is the only commercially available, high-volume perinatal MSC bioprocess system with a line of sight to towards clinical translation.

“Until now, there was not a hUC-MSC on the market that would support the quality and scale needs of cell therapy product developers,” said RoosterBio Founder & Chief Product Officer Jon A. Rowley, PhD. RoosterBio’s launch of RoosterVial-hUC-MSC-XF introduces another first-in-class hMSC product on the market that simplifies all aspects of product development. “This very powerful set of biological tools has now been released into the Regenerative Medicine marketplace, introducing a major step-change in MSC productivity,” added Dr. Rowley.

The adoption of umbilical cord hMSC product development in Asia and Europe has demonstrated hUC-MSCs are the fastest growing tissue type and second in overall usage within hMSC Regenerative Medicine applications, according to recent global research publications. hUC-MSC product development in North America has been slower to develop due to the lack of availability of this critical raw material.

RoosterBio’s xeno-free hUC-MSCs are isolated from the perivascular Wharton’s Jelly region of the human umbilical cord and is collected after birth. “RoosterBio’s first-in-class characterization of hUC-MSC key quality attributes along with our readily implementable process recommendations gives added confidence in quality, reproducibility, and ease of integration,” said Dr. Rowley. “By introducing new tissue types, we are opening the door to support the incorporation of these new living cellular technologies into product development across the globe.”

Along with RoosterBio’s paired bioprocess media system, RoosterVial-hUC reaches new levels in hMSC expansion in terms of M cells/L media consumed as well as extracellular vesicle (EV) productivity. The product is backed by licensed intellectual property (IP) from Tissue Regeneration Therapeutics (TRT), a Canadian Controlled Private Corporation with a focus on Human Umbilical Cord PeriVascular Cell (HUCPVC) technology.

RoosterBio announced the collaboration with Tissue Regeneration Therapeutics in May 2019 which gave RoosterBio an exclusive worldwide license to TRT’s patent estate related to the manufacture and global sale of human umbilical cord-derived MSCs. The announcement advances both companies shared goal of accelerating the development of the Regenerative Medicine industry.

Visit https://www.roosterbio.com/collections/high-volume-hmscs for more information about RoosterBio’s radically simplified xeno-free hUC-MSCs.

About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Read the full story at https://www.prweb.com/releases/roosterbio_launches_the_only_umbilical_cord_hmsc_system_in_the_world_designed_for_cell_therapy_product_development/prweb16551515.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. RoosterBio Will Attend Society for Biomaterials Annual Meeting April 3-6, 2019
2. RoosterBio Announces Plans to Expand Facility in Frederick, MD
3. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
4. RoosterBio, Inc. Earns NIIMBL Nod with 2 Grant Awards for Regenerative Medicine Manufacturing
5. BioInformatics Launches New Experts-on-Demand Qualitative Research Service
6. Deep Science Ventures Launches Europe’s First Venture-Building Programme for Food & Agriculture
7. ActX Launches a Genetic Medical Interpretation Service for 23andMe Customers
8. FileWave Launches Version 13.1
9. ASGCT Launches Clinical Trials Finder on Clinical Trials Day 2019
10. Akadeum Launches Seven New Products at Immunology 2019 Conference in San Diego
11. FISO Technologies Launches the FOP-M200, the Smallest Commercially Available Pressure Transducer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation ... binding assays (LBA) have dominated this area. However, the use of mass spectrometry in ... This now necessitates the question “How do you choose which approach to use (LBA ...
(Date:6/19/2020)... ... 16, 2020 , ... The director of stem cell biotechnology company Asymmetrex ... medicine and pharmaceutical industries have easier access to stem cell counting, they will soon ... this year, Independence Day weekend in the U.S., Asymmetrex is offering free tissue stem ...
(Date:6/13/2020)... , ... June 11, 2020 , ... ... services, announces a significant expansion of its forensic genealogy team. Bode’s Forensic ... attorneys through proven forensic genealogy and DNA analysis methods. The team has added ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 2020 , ... DeCurtis Corporation, the premier provider of location ... has been appointed CEO and President. Founder and former CEO, David DeCurtis, will ... Corporation has been on an incredible journey for the last twenty years, and ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace project was founded ... forces to radically prolong life and find a way (medicine or technology) that will ... was supported by various scientists from all over the world, doctors, and all people ...
(Date:6/11/2020)... ... , ... Reducing carbon emissions has been and will continue to be a ... dips, ways to reduce CO2 is something we can’t avoid. , To protect ... being produced today are created from recycled cooking oil or crops. Unfortunately, these sources ...
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum is ... solely dedicated to the unique role of the Chief Medical Officer in the ... responsibilities, problem-solving, best practices and career development of CMOs and Heads of R&D ...
Breaking Biology Technology: